Technical Articles

MHC II类四聚体技术:破解肿瘤免疫逃逸的新钥匙
MHC class II tetramer technology: a new key to cracking tumor immune escape
发布时间 2025-08-22
One of the main strategies for tumor cells to evade T cell recognition is to downregulate MHC molecule expression. When MHC molecules are deficient, tumor cells no longer present mutant antigens, causing T cells to lose their tracking and attacking targets, thus allowing them to proliferate "invisibly". This mechanism is particularly common in solid tumors, posing a huge challenge to immunotherapy
View details
  • Cancer
  • MHC class II tetramer technology for tumors
  • immunology
Total 1
  • 1
Go to